These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 30810945)
1. Serum miR-30c-5p is a potential biomarker for multiple system atrophy. Vallelunga A; Iannitti T; Dati G; Capece S; Maugeri M; Tocci E; Picillo M; Volpe G; Cozzolino A; Squillante M; Cicarelli G; Barone P; Pellecchia MT Mol Biol Rep; 2019 Apr; 46(2):1661-1666. PubMed ID: 30810945 [TBL] [Abstract][Full Text] [Related]
2. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease. Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501 [TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy. Marques TM; Kuiperij HB; Bruinsma IB; van Rumund A; Aerts MB; Esselink RAJ; Bloem BR; Verbeek MM Mol Neurobiol; 2017 Dec; 54(10):7736-7745. PubMed ID: 27844283 [TBL] [Abstract][Full Text] [Related]
4. Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy. Vallelunga A; Ragusa M; Di Mauro S; Iannitti T; Pilleri M; Biundo R; Weis L; Di Pietro C; De Iuliis A; Nicoletti A; Zappia M; Purrello M; Antonini A Front Cell Neurosci; 2014; 8():156. PubMed ID: 24959119 [TBL] [Abstract][Full Text] [Related]
5. Serum miR-96-5P and miR-339-5P Are Potential Biomarkers for Multiple System Atrophy and Parkinson's Disease. Vallelunga A; Iannitti T; Capece S; Somma G; Russillo MC; Foubert-Samier A; Laurens B; Sibon I; Meissner WG; Barone P; Pellecchia MT Front Aging Neurosci; 2021; 13():632891. PubMed ID: 34381349 [TBL] [Abstract][Full Text] [Related]
6. Identification of microRNAs for the early diagnosis of Parkinson's disease and multiple system atrophy. Yan JH; Hua P; Chen Y; Li LT; Yu CY; Yan L; Zhang H; He Y; Zheng H; Chen H; Zhang ZJ; Yao QH; Dong H; Liu WG J Integr Neurosci; 2020 Sep; 19(3):429-436. PubMed ID: 33070521 [TBL] [Abstract][Full Text] [Related]
7. The biomarker potential of cell-free microRNA from cerebrospinal fluid in Parkinsonian Syndromes. Starhof C; Hejl AM; Heegaard NHH; Carlsen AL; Burton M; Lilje B; Winge K Mov Disord; 2019 Feb; 34(2):246-254. PubMed ID: 30557454 [TBL] [Abstract][Full Text] [Related]
8. Combining salivary α-synuclein seeding activity and miRNA-29a to distinguish Parkinson's disease and multiple system atrophy. Luan M; Wei L; Sun Y; Chen J; Jiang Y; Wu W; Li F; Sun W; Zhu L; Wang Z; Deng J Parkinsonism Relat Disord; 2024 Oct; 127():107088. PubMed ID: 39111257 [TBL] [Abstract][Full Text] [Related]
9. Serum microRNA expression profiling in patients with multiple system atrophy. Kume K; Iwama H; Deguchi K; Ikeda K; Takata T; Kokudo Y; Kamada M; Fujikawa K; Hirose K; Masugata H; Touge T; Masaki T Mol Med Rep; 2018 Jan; 17(1):852-860. PubMed ID: 29115515 [TBL] [Abstract][Full Text] [Related]
10. Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease. He S; Huang L; Shao C; Nie T; Xia L; Cui B; Lu F; Zhu L; Chen B; Yang Q Transl Neurodegener; 2021 Jul; 10(1):25. PubMed ID: 34315539 [TBL] [Abstract][Full Text] [Related]
11. Differential expression and significance of miRNAs in plasma extracellular vesicles of patients with Parkinson's disease. Xie S; Niu W; Xu F; Wang Y; Hu S; Niu C Int J Neurosci; 2022 Jul; 132(7):673-688. PubMed ID: 33045885 [TBL] [Abstract][Full Text] [Related]
12. A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease. Dong H; Wang C; Lu S; Yu C; Huang L; Feng W; Xu H; Chen X; Zen K; Yan Q; Liu W; Zhang C; Zhang CY Biomarkers; 2016; 21(2):129-37. PubMed ID: 26631297 [TBL] [Abstract][Full Text] [Related]
13. Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson's disease. Chen Q; Deng N; Lu K; Liao Q; Long X; Gou D; Bi F; Zhou J Sci Rep; 2021 Jul; 11(1):15268. PubMed ID: 34315950 [TBL] [Abstract][Full Text] [Related]
14. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients. Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580 [TBL] [Abstract][Full Text] [Related]
16. Circulating miR-29c, miR-30c, miR-193a-5p and miR-885-5p: Novel potential biomarkers for HTLV-1 infection diagnosis. Fayyad-Kazan M; ElDirani R; Hamade E; El Majzoub R; Akl H; Bitar N; Fayyad-Kazan H; Badran B Infect Genet Evol; 2019 Oct; 74():103938. PubMed ID: 31242452 [TBL] [Abstract][Full Text] [Related]
17. Serum miR-221 serves as a biomarker for Parkinson's disease. Ma W; Li Y; Wang C; Xu F; Wang M; Liu Y Cell Biochem Funct; 2016 Oct; 34(7):511-515. PubMed ID: 27748571 [TBL] [Abstract][Full Text] [Related]
18. Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study. Manna I; Quattrone A; De Benedittis S; Vescio B; Iaccino E; Quattrone A Parkinsonism Relat Disord; 2021 Dec; 93():77-84. PubMed ID: 34839044 [TBL] [Abstract][Full Text] [Related]
19. Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease. Ding H; Huang Z; Chen M; Wang C; Chen X; Chen J; Zhang J Parkinsonism Relat Disord; 2016 Jan; 22():68-73. PubMed ID: 26631952 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA Deregulation in Blood Serum Identifies Multiple System Atrophy Altered Pathways. Pérez-Soriano A; Bravo P; Soto M; Infante J; Fernández M; Valldeoriola F; Muñoz E; Compta Y; Tolosa E; Garrido A; Ezquerra M; Fernández-Santiago R; Martí MJ; Mov Disord; 2020 Oct; 35(10):1873-1879. PubMed ID: 32687224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]